Trial Profile
Multicentre, parallel group, randomised, double blind study to investigate the efficacy of Montelukast (MK) + Fluticasone (FP) placebo versus Fluticasone + MK-placebo versus MK-placebo + FP-placebo in preschool children with asthma or asthma-like symptoms during a 3 months study period.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Acronyms OBELIKS
- Sponsors Merck Sharp & Dohme
- 15 Sep 2009 New trial record